147 related articles for article (PubMed ID: 22034503)
1. Serum free light chains and the risk of ESRD and death in CKD.
Haynes R; Hutchison CA; Emberson J; Dasgupta T; Wheeler DC; Townend JN; Landray MJ; Cockwell P
Clin J Am Soc Nephrol; 2011 Dec; 6(12):2829-37. PubMed ID: 22034503
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
[TBL] [Abstract][Full Text] [Related]
3. The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysis.
Fraser SDS; Fenton A; Harris S; Shardlow A; Liabeuf S; Massy ZA; Burmeister A; Hutchison CA; Landray M; Emberson J; Kalra PA; Ritchie JP; Cockwell P; Taal MW
Mayo Clin Proc; 2017 Nov; 92(11):1671-1681. PubMed ID: 29101935
[TBL] [Abstract][Full Text] [Related]
4. The association of serum-free light-chain levels with markers of renal function.
Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of CKD patients receiving outpatient nephrology care in Italy.
De Nicola L; Chiodini P; Zoccali C; Borrelli S; Cianciaruso B; Di Iorio B; Santoro D; Giancaspro V; Abaterusso C; Gallo C; Conte G; Minutolo R;
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2421-8. PubMed ID: 21817127
[TBL] [Abstract][Full Text] [Related]
6. Serum-free light chains in HIV-associated lymphoma: no correlation with histology or prognosis.
Tittle V; Rayment M; Keeling E; Gabriel I; Yarranton H; Bower M
AIDS; 2015 Jun; 29(10):1201-4. PubMed ID: 26035320
[TBL] [Abstract][Full Text] [Related]
7. Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study.
Landray MJ; Emberson JR; Blackwell L; Dasgupta T; Zakeri R; Morgan MD; Ferro CJ; Vickery S; Ayrton P; Nair D; Dalton RN; Lamb EJ; Baigent C; Townend JN; Wheeler DC
Am J Kidney Dis; 2010 Dec; 56(6):1082-94. PubMed ID: 21035932
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.
Hutchison CA; Harding S; Hewins P; Mead GP; Townsend J; Bradwell AR; Cockwell P
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1684-90. PubMed ID: 18945993
[TBL] [Abstract][Full Text] [Related]
9. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of serum free light chains in renal transplantation.
Sánchez-Castañón M; Gago M; Fernandez-Fresnedo G; Gomez-Alamillo C; Ruiz-Criado J; Lopez-Hoyos M; Arias M
Transplant Proc; 2010 Oct; 42(8):2861-3. PubMed ID: 20970552
[TBL] [Abstract][Full Text] [Related]
11. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
[TBL] [Abstract][Full Text] [Related]
12. First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease.
Tsai CW; Huang HC; Chiang HY; Chung CW; Chiu HT; Liang CC; Yu T; Kuo CC
Nephrol Dial Transplant; 2019 Dec; 34(12):2066-2078. PubMed ID: 29982714
[TBL] [Abstract][Full Text] [Related]
13. Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study.
Fenton A; Chinnadurai R; Gullapudi L; Kampanis P; Dasgupta I; Ritchie J; Harding S; Ferro CJ; Kalra PA; Taal MW; Cockwell P
PLoS Med; 2020 Feb; 17(2):e1003050. PubMed ID: 32109242
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease.
Agarwal R
Clin J Am Soc Nephrol; 2009 Apr; 4(4):830-7. PubMed ID: 19339424
[TBL] [Abstract][Full Text] [Related]
15. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
Provenzano M; Chiodini P; Minutolo R; Zoccali C; Bellizzi V; Conte G; Locatelli F; Tripepi G; Del Vecchio L; Mallamaci F; Di Micco L; Russo D; Heerspink HJL; De Nicola L
Nephrol Dial Transplant; 2020 Jan; 35(1):138-147. PubMed ID: 30053127
[TBL] [Abstract][Full Text] [Related]
16. Change in novel filtration markers and risk of ESRD.
Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
[TBL] [Abstract][Full Text] [Related]
17. Are renal reference intervals required when screening for plasma cell disorders with serum free light chains and serum protein electrophoresis?
Abadie JM; van Hoeven KH; Wells JM
Am J Clin Pathol; 2009 Feb; 131(2):166-71. PubMed ID: 19141376
[TBL] [Abstract][Full Text] [Related]
18. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.
Berhane AM; Weil EJ; Knowler WC; Nelson RG; Hanson RL
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2444-51. PubMed ID: 21852671
[TBL] [Abstract][Full Text] [Related]
19. Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype.
Scarpa R; Pulvirenti F; Pecoraro A; Vultaggio A; Marasco C; Ria R; Altinier S; Compagno N; Firinu D; Plebani M; De Carli M; Matucci A; Vianello F; Vacca A; Spadaro G; Quinti I; Agostini C; Milito C; Cinetto F
Front Immunol; 2020; 11():319. PubMed ID: 32296413
[TBL] [Abstract][Full Text] [Related]
20. Short-term change in kidney function and risk of end-stage renal disease.
Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
